Zhuhai Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHUHAI
ZHUHAI has one approved drug.
There are three US patents protecting ZHUHAI drugs.
There are three patent family members on ZHUHAI drugs in two countries and three supplementary protection certificates in three countries.
Summary for Zhuhai
| International Patents: | 3 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Zhuhai
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhuhai | BEIZRAY | docetaxel | SOLUTION;INTRAVENOUS | 218711-001 | Oct 23, 2024 | RX | Yes | Yes | 12,090,135 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zhuhai | BEIZRAY | docetaxel | SOLUTION;INTRAVENOUS | 218711-001 | Oct 23, 2024 | RX | Yes | Yes | 12,090,134 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Zhuhai | BEIZRAY | docetaxel | SOLUTION;INTRAVENOUS | 218711-001 | Oct 23, 2024 | RX | Yes | Yes | 11,419,842 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zhuhai Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2018081520 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2018081520 | ⤷ Start Trial |
| China | 115487312 | ⤷ Start Trial |
| China | 110062622 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zhuhai Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1667986 | 92172 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| 1667986 | 28/2013 | Austria | ⤷ Start Trial | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 0253738 | C960002 | Netherlands | ⤷ Start Trial | PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
